Avanos Medical Inc (AVNS)
13.45 x 1 15.61 x 1
Post-market by (Cboe BZX)
14.03 -0.49 (-3.37%) 04/03/25 [NYSE]
13.45 x 1 15.61 x 1
Post-market 14.03 unch (unch) 16:02 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | AVNS | IRMD | MLAB | ||
| Company | Avanos Medical Inc | Iradimed Corp | Mesa Labs Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 14.17 | 52.03 | 113.05 | ||
| High | 14.28 | 52.03 | 113.19 | ||
| Low | 13.82 | 50.81 | 107.97 | ||
| Last | 14.03 | 51.36 | 108.39 | ||
| Change | -0.49 | -2.24 | -12.30 | ||
| % Change | -3.37% | -4.18% | -10.19% | ||
| Volume | 491,347 | 25,900 | 57,385 | ||
| 20-Day Average Volume | 529,512 | 35,725 | 50,009 | ||
| Previous Close | 14.52 | 53.60 | 120.69 | ||
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 14.51 | 52.52 | 123.64 | ||
| 20-Day Raw Stochastic | 12.00% | 21.49% | 1.23% | ||
| 20-Day Relative Strength | 36.92% | 40.24% | 34.07% | ||
| Weighted Alpha | -35.06 | +15.87 | -2.76 | ||
| Today's Opinion | 100% Sell | 8% Sell | 24% Sell | ||
| Previous Opinion | 100% Sell | 24% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 24% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.09% since 03/27/25 | -3.78% since 03/27/25 | -13.04% since 03/27/25 | ||
| Low | 13.82 on 04/03/25 | 50.81 on 04/03/25 | 107.97 on 04/03/25 | ||
| High | 14.53 on 04/02/25 | 54.10 on 04/01/25 | 125.00 on 03/28/25 | ||
| 1-Month | |||||
| %Chg | -7.27% since 03/03/25 | -3.62% since 03/03/25 | -19.97% since 03/03/25 | ||
| Low | 13.82 on 04/03/25 | 50.61 on 03/13/25 | 107.97 on 04/03/25 | ||
| High | 15.57 on 03/07/25 | 54.10 on 04/01/25 | 142.18 on 03/07/25 | ||
| 3-Month | |||||
| %Chg | -9.77% since 01/03/25 | -7.49% since 01/03/25 | -21.66% since 01/03/25 | ||
| Low | 13.82 on 04/03/25 | 49.56 on 02/13/25 | 107.97 on 04/03/25 | ||
| High | 17.69 on 01/30/25 | 63.29 on 02/05/25 | 155.12 on 02/10/25 | ||
| 6-Month | |||||
| %Chg | -39.05% since 10/03/24 | +4.45% since 10/03/24 | -17.04% since 10/03/24 | ||
| Low | 13.82 on 04/03/25 | 46.86 on 10/31/24 | 97.90 on 11/20/24 | ||
| High | 23.68 on 10/18/24 | 63.29 on 02/05/25 | 155.12 on 02/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 667,963 | 681,524 | 655,780 | ||
| Shares Outstanding, K | 46,003 | 12,715 | 5,434 | ||
| Annual Sales | 687,800,000 | 73,240,000 | 216,190,000 | ||
| Annual Net Income | -392,100,000 | 19,230,000 | -254,250,000 | ||
| Last Quarter Sales | 179,600,000 | 19,390,000 | 62,840,000 | ||
| Last Quarter Net Income | -397,300,000 | 5,150,000 | -1,680,000 | ||
| 60-Month Beta | 1.15 | 0.82 | 0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.43 on 02/26/25 | 0.44 on 02/13/25 | 2.67 on 02/04/25 | ||
| Latest Earnings Date | 05/01/25 | 05/01/25 | 02/04/25 | ||
| Most Recent Dividend | N/A | 0.170 on 02/24/25 | 0.160 on 02/28/25 | ||
| Next Ex-Dividends Date | N/A | 02/24/25 | 02/28/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.63 | 35.63 | 13.95 | ||